Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

UNLV Student Health Center senior pharmacist prepares vaccine. Photo: Ethan Miller/Getty Images

Scientists launched a National Institutes of Health-backed study with thousands of college students to determine whether Moderna's COVID vaccine can prevent asymptomatic spread of the virus.

Why it matters: The results of the trial could provide vaccinated individuals insight on how careful they really need to be when in close contact with others.

What they're saying: "This is a question of extreme importance," Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said at a press briefing on Friday.

  • "But the prevailing question is when these people get infected, how often is that? If they’re asymptomatic, how much virus do they have in their nose and do they transmit it to people who are their close contacts?" he added.

The state of play: The study, which launched Thursday, is looking for 12,000 college students to volunteer across 21 campuses, including the University of Maryland, the University of North Carolina, Texas A&M and Indiana University.

  • Students can sign up here, with multiple ways to participate. "You can finally fall asleep in class, not Zoom," the site says.
  • Half of the volunteers will be randomly selected to receive Moderna's vaccine right away. The other half will receive their shots in roughly four months.
  • Researchers will track the students by having them swab their noses and place the specimen in bar-coded vials for collection. Blood samples will be taken to test for antibodies and tracked through an app.
  • Some student volunteers can get paid almost $1,000 to participate fully.

The bottom line: The results, which are anticipated in September, will equip the public and federal government with science-based evidence on mask use and social distancing post-vaccination.

Go deeper

Updated Mar 26, 2021 - Axios Twin Cities

Minnesota to expand COVID vaccine eligibility to everyone over 16 on March 30

Illustration: Brendan Lynch/Axios

All Minnesotans 16 and older will be eligible to sign up for a COVID-19 vaccine appointment starting Tuesday, Gov. Tim Walz announced Wednesday

Why it matters: It's coming at a critical time in our quest to return to pre-pandemic life. While hospitalizations and deaths remain down, cases are rising, especially among young people.

Mar 26, 2021 - Health

The new vaccine waiting game

Illustration: Sarah Grillo/Axios

Congratulations! You're about to be eligible to ... wait some more for the vaccine.

The big picture: States are expanding eligibility for COVID vaccines by broad age groups — and some are opening it to all adults. But that doesn't always mean they have enough vaccine supplies to offer appointments to everyone in the new groups.